Evolent Health, Inc. EVH Cases — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s cases — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s cases — revenue?
- Evolent Health, Inc. (EVH) reported cases — revenue of $42.56M in Q1 2026.
- How has Evolent Health, Inc.'s cases — revenue changed year-over-year?
- Evolent Health, Inc.'s cases — revenue increased by 4.8% year-over-year, from $40.62M to $42.56M.
- What is the long-term trend for Evolent Health, Inc.'s cases — revenue?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s cases — revenue has grown at a 144.9% compound annual growth rate (CAGR), from $4.69M to $168.98M.
- What does cases — revenue mean?
- This metric represents the total revenue generated from the company's specialized care management services, specifically focusing on oncology, cardiology, and musculoskeletal markets. It reflects the financial performance of the segment dedicated to managing complex clinical conditions and total cost of care for health systems and physician organizations. Growth in this segment indicates successful adoption of value-based care solutions and the expansion of specialized clinical management capabilities.